Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial
Titel:
Keratinocyte growth factor for the treatment of the acute respiratory distress syndrome (KARE): a randomised, double-blind, placebo-controlled phase 2 trial
Auteur:
McAuley, Daniel F Cross, LJ Mark Hamid, Umar Gardner, Evie Elborn, J Stuart Cullen, Kathy M Dushianthan, Ahilanandan Grocott, Michael PW Matthay, Michael A O'Kane, Cecilia M